Phosphatidylinositol 4,5-bisphosphate competitively inhibits phorbol ester binding to protein kinase C.
Calcium phospholipid dependent protein kinase C (PKC) is activated by diacylglycerol (DG) and by phorbol esters and is recognized to be the phorbol ester receptor of cells; DG displaces phorbol ester competitively from PKC. A phospholipid, phosphatidylinositol 4,5-bisphosphate (PIP2), can also activate PKC in the presence of phosphatidylserine (PS) and Ca2+ with a KPIP2 of 0.04 mol %. Preliminary experiments have suggested a common binding site for PIP2 and DG on PKC. Here, we investigate the effect of PIP2 on phorbol ester binding to PKC in a mixed micellar assay. In the presence of 20 mol % PS, PIP2 inhibited specific binding of [3H]phorbol 12,13-dibutyrate (PDBu) in a dose-dependent fashion up to 85% at 1 mol %. Inhibition of binding was more pronounced with PIP2 than with DG. Scatchard analysis indicated that the decrease in binding of PDBu in the presence of PIP2 is the result of an altered affinity for the phorbol ester rather than of a change in maximal binding. The plot of apparent dissociation constants (Kd') against PIP2 concentration was linear over a range of 0.01-1 mol % with a Ki of 0.043 mol % and confirmed the competitive nature of inhibition between PDBu and PIP2. Competition between PIP2 and phorbol ester could be demonstrated in a liposomal assay system also. These results indicate that PIP2, DG, and phorbol ester all compete for the same activator-receiving region on the regulatory moiety of protein kinase C, and they lend support to the suggestion that PIP2 is a primary activator of the enzyme.
Chauhan
A
A
New York State Office of Mental Retardation and Developmental Disabilities, Institute for Basic Research in Developmental Disabilities, Staten Island.
Chauhan
V P
VP
Deshmukh
D S
DS
Brockerhoff
H
H
D001665:Binding Sites / Q000187:drug effects; D001667:Binding, Competitive; D004789:Enzyme Activation / Q000187:drug effects; D005989:Glycerides / Q000494:pharmacology; D008081:Liposomes; D017830:Octoxynol; D010703:Phorbol Esters / Q000032:analysis*; D019269:Phosphatidylinositol 4,5-Diphosphate; D010716:Phosphatidylinositols / Q000494:pharmacology*; D011092:Polyethylene Glycols / Q000032:analysis; D011487:Protein Conformation; D011493:Protein Kinase C / Q000037:antagonists & inhibitors*
D005989:Glycerides; D008081:Liposomes; D010703:Phorbol Esters; D019269:Phosphatidylinositol 4,5-Diphosphate; D010716:Phosphatidylinositols; D011092:Polyethylene Glycols; D017830:Octoxynol; D011493:Protein Kinase C